Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New data submitted in support of clofarabine NDA

Aug. 31, 2004

Phase II results on the activity of BMS-247550 monotherapy in advanced colorectal cancer

Aug. 31, 2004

Roche seeks European approval of Tarceva for NSCLC

Aug. 30, 2004

IND filing for Provecta

Aug. 30, 2004

New caspase activators prepared and tested by Cytovia researchers

Aug. 30, 2004

Antiangiogenic agents targeting VEGFR kinase designed at Novartis

Aug. 30, 2004

Sterix presents new dual aromatase/steroid sulfatase inhibitor

Aug. 26, 2004

Roche seeks new indication for Xeloda in U.S., E.U.

Aug. 26, 2004

HGS-TR2J enters clinical development

Aug. 26, 2004

CuraGen collaborates with NCI on PXD-101 development

Aug. 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...